Cost effectiveness of empagliflozin in adult patients with chronic kidney disease in the Netherlands

Bart Slob*, Tanja Fens, Maaike Weersma, Maarten Postma, Cornelis Boersma, Lisa de Jong

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Cost effectiveness of empagliflozin in adult patients with chronic kidney disease in the Netherlands'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science